Skip to main content

Table 3 Frequency distribution of all drug-related adverse events of at least grade 3

From: Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction

 

Dose level

 

Event

1

2

3

Total

Number of patients

4 (100%)

13 (100%)

7 (100%)

24 (100%)

Nausea

1 (25%)

2 (15%)

3 (43%)

6 (25%)

Vomiting

2 (50%)

2 (15%)

1 (14%)

5 (21%)

Dehydration

  

1 (14%)

1 (4%)

Diarrhoea

  

1 (14%)

1 (4%)

Dysphagia

 

1 (8%)

 

1 (4%)

Heartburn/dyspepsia

  

1 (14%)

1 (4%)

Fatigue

1 (25%)

1 (8%)

3 (43%)

5 (21%)

Pain

  

1 (14%)

1 (4%)

Platelets

 

1 (8%)

1 (14%)

2 (8%)

Leukocytes

  

1 (14%)

1 (4%)

Neutrophils

  

1 (14%)

1 (4%)